Davidson Investment Advisors Pfizer Inc Transaction History

Davidson Investment Advisors

$2.04 Billion
Q3 2024

A detailed history of Davidson Investment Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Davidson Investment Advisors holds 450,948 shares of PFE stock, worth $12.1 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

450,948

Previous 442,122 2.0%

Holding current value

$12.1 Million

Previous $12.4 Million 5.5%

% of portfolio

0.64%

Previous 0.65%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $244,480 - $277,048	8,826 Added 2.0%	450,948 $13.1 Million
Q2 2024 Jul 31, 2024	SELL	$25.26 - $29.6 $154,389 - $180,915	-6,112 Reduced 1.36%	442,122 $12.4 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $2.86 Million - $3.28 Million	110,313 Added 32.64%	448,234 $12.4 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $195,687 - $254,176	-7,489 Reduced 2.17%	337,921 $9.73 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $166,803 - $194,976	5,198 Added 1.53%	345,410 $11.5 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $11,486 - $13,289	318 Added 0.09%	340,212 $12.5 Million
Q1 2023 Aug 22, 2023	SELL	$39.39 - $51.28 $12,526 - $16,307	-318 Reduced 0.09%	339,894 $13.9 Million
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $37,302 - $48,562	947 Added 0.28%	339,894 $13.9 Million
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $192,342 - $251,081	-4,607 Reduced 1.34%	338,947 $17.4 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $485,692 - $592,908	11,099 Added 3.34%	343,554 $15 Million
Q2 2022 Jul 27, 2022	BUY	$46.53 - $55.17 $18,053 - $21,405	388 Added 0.12%	332,455 $17.4 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $120,048 - $148,754	2,624 Added 0.8%	332,067 $17.2 Million
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $4.48 Million - $6.63 Million	-108,308 Reduced 24.74%	329,443 $19.5 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $152,878 - $196,385	-3,895 Reduced 0.88%	437,751 $18.8 Million
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $500,621 - $567,119	-13,941 Reduced 3.06%	441,646 $17.3 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $524,687 - $591,742	-15,667 Reduced 3.32%	455,587 $16.5 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $230,240 - $292,770	-6,879 Reduced 1.44%	471,254 $17.3 Million
Q3 2020 Nov 02, 2020	SELL	$31.75 - $37.25 $704,278 - $826,279	-22,182 Reduced 4.43%	478,133 $17.5 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $828,962 - $1.01 Million	27,522 Added 5.82%	500,315 $16.4 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $444,183 - $634,642	-16,433 Reduced 3.36%	472,793 $15.4 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $137,144 - $155,641	-4,166 Reduced 0.84%	489,226 $19.2 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $995,623 - $1.29 Million	-30,644 Reduced 5.85%	493,392 $17.7 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $461,917 - $518,626	-12,491 Reduced 2.33%	524,036 $22.7 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $328,650 - $361,076	-8,764 Reduced 1.61%	536,527 $0
Q4 2018 Jan 29, 2019	BUY	$38.47 - $43.86 $192,042 - $218,949	4,992 Added 0.92%	545,291 $23.8 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $141,085 - $171,128	4,093 Added 0.76%	540,299 $23.8 Million
Q2 2018 Aug 02, 2018	SELL	$32.98 - $35.16 $205,201 - $218,765	-6,222 Reduced 1.15%	536,206 $19.5 Million
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $464,162 - $538,492	-14,546 Reduced 2.61%	542,428 $19.3 Million
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $74,469 - $79,014	2,239 Added 0.4%	556,974 $20.2 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $2.7 Million - $2.97 Million	86,999 Added 18.6%	554,735 $19.8 Million
Q2 2017 Aug 11, 2017	BUY	N/A	467,736	467,736 $15.7 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Investment Advisors with notifications on news.

Account

Davidson Investment Advisors Pfizer Inc Transaction History